Literature DB >> 19049600

Calorie restriction and glucose regulation.

Kelvin A Yamada1.   

Abstract

Ketogenic diets (KDs) are effective treatments for epilepsy. The mechanisms of action are poorly understood. In some experimental seizure models, calorie restriction and hypoglycemia may augment the antiseizure effects of KDs. In addition, inhibiting glycolysis or diverting glucose from the glycolytic pathway inhibits seizures and possibly epileptogenesis, suggesting an interaction between energy regulation and the anticonvulsant actions of these interventions. Children on KDs frequently exhibit poor weight gain and have lower blood glucose levels compared to children on standard, balanced diets. Young rodents on a KD also exhibit slow weight gain, lower blood glucose and insulin levels, and elevated leptin levels. This review considers the possibility that calorie restriction, low serum glucose, and KDs share common cell signaling pathways to alter brain excitability. AMP-activated protein kinase (AMPK) is an attractive candidate signaling protein that could link energy balance to gene expression in such a way so as to reduce brain excitability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049600     DOI: 10.1111/j.1528-1167.2008.01847.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Seizure tests distinguish intermittent fasting from the ketogenic diet.

Authors:  Adam L Hartman; Xiangrong Zheng; Emily Bergbower; Michiko Kennedy; J Marie Hardwick
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

Review 2.  Stroke outcome in the ketogenic state--a systematic review of the animal data.

Authors:  Claire L Gibson; Anne N Murphy; Sean P Murphy
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

3.  Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota.

Authors:  Jingwei Cai; Limin Zhang; Richard A Jones; Jared B Correll; Emmanuel Hatzakis; Philip B Smith; Frank J Gonzalez; Andrew D Patterson
Journal:  J Proteome Res       Date:  2016-01-12       Impact factor: 4.466

4.  The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

Authors:  Sharon S McDaniel; Nicholas R Rensing; Liu Lin Thio; Kelvin A Yamada; Michael Wong
Journal:  Epilepsia       Date:  2011-03-03       Impact factor: 5.864

5.  Increased Hippocampal Afterdischarge Threshold in Ketogenic Diet is Accompanied by Enhanced Kynurenine Pathway Activity.

Authors:  Bartosz Osuch; Karolina Kołosowska; Natalia Chmielewska; Danuta Turzyńska; Alicja Sobolewska; Janusz Szyndler; Piotr Maciejak
Journal:  Neurochem Res       Date:  2022-05-06       Impact factor: 3.996

6.  Regulation of kynurenine metabolism by a ketogenic diet.

Authors:  Svenja Heischmann; Lindsey B Gano; Kevin Quinn; Li-Ping Liang; Jacek Klepacki; Uwe Christians; Nichole Reisdorph; Manisha Patel
Journal:  J Lipid Res       Date:  2018-03-31       Impact factor: 5.922

Review 7.  Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Authors:  Adam L Hartman; Carl E Stafstrom
Journal:  Epilepsy Behav       Date:  2012-10-27       Impact factor: 2.937

Review 8.  Ketogenic Diets for Adult Neurological Disorders.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

9.  The ketogenic diet as a treatment paradigm for diverse neurological disorders.

Authors:  Carl E Stafstrom; Jong M Rho
Journal:  Front Pharmacol       Date:  2012-04-09       Impact factor: 5.810

10.  Caloric restriction protects against electrical kindling of the amygdala by inhibiting the mTOR signaling pathway.

Authors:  Bryan V Phillips-Farfán; María Del Carmen Rubio Osornio; Verónica Custodio Ramírez; Carlos Paz Tres; Karla G Carvajal Aguilera
Journal:  Front Cell Neurosci       Date:  2015-03-11       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.